Publication

Monkeypox emergency: Urgent questions and perspectives

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Stefan Rothenburg, University of California DavisZhilong Yang, Texas A&M UniversityPip Beard, Pirbright InstituteSara L. Sawyer, University of Colorado BoulderBoghuma Titanji, Emory UniversityGregg Gonsalves, Yale UniversityJason Kindrachuk, University of Manitoba
Language
  • English
Date
  • 2022-09-01
Publisher
  • CELL PRESS
Publication Version
Copyright Statement
  • © 2022 Published by Elsevier Inc.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 185
Issue
  • 18
Start Page
  • 3279
End Page
  • 3281
Abstract
  • Amidst the COVID-19 pandemic, we now face another public health emergency in the form of monkeypox virus. As of August 1, the Centers for Disease Control and Prevention report over 23,000 cases in 80 countries. An inclusive and global collaborative effort to understand the biology, evolution, and spread of the virus as well as commitment to vaccine equity will be critical toward containing this outbreak. We share the voices of leading experts in this space on what they see as the most pressing questions and directions for the community.
Author Notes
  • S.L.S. is a founder of Darwin Biosciences and a member of its scientific advisory board. She serves as a consultant for the MITRE Corp. and as a senior editor at the journal eLife. She is a member of the Planning Committee for Countering Zoonotic Spillover of High Consequence Pathogens, sponsored by the Academies of Sciences, Engineering, and Medicine. B.T. has received consulting fees for the non-profit organization CRITICA for work unrelated to the present publication.
Keywords
Research Categories
  • Biology, Cell
  • Biology, Molecular
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items